CREB engages C/EBPδ to initiate leukemogenesis

[1]  Taira Maekawa,et al.  Non-steady-state hematopoiesis regulated by the C/EBPβ transcription factor , 2015, Cancer science.

[2]  B. Geoerger,et al.  Patients in Pediatric Phase I and Early Phase II Clinical Oncology Trials at Gustave Roussy: A 13-Year Center Experience , 2015, Journal of pediatric hematology/oncology.

[3]  R. Ribeiro.  Advances in treatment of de-novo pediatric acute myeloid leukemia , 2014, Current opinion in oncology.

[4]  F. Locatelli,et al.  Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations , 2014, Leukemia.

[5]  Jason J Burbank,et al.  Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia. , 2014, The Journal of clinical investigation.

[6]  S. Rutella,et al.  Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. , 2013, Blood.

[7]  G. Basso,et al.  MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation , 2013, Haematologica.

[8]  G. Vassal,et al.  New drugs for children and adolescents with cancer: the need for novel development pathways. , 2013, The Lancet. Oncology.

[9]  Bas J. Wouters,et al.  C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia. , 2012, The Journal of clinical investigation.

[10]  K. Sakamoto,et al.  Sox4 cooperates with CREB in myeloid transformation. , 2012, Blood.

[11]  Leonard I Zon,et al.  Hooked! Modeling human disease in zebrafish. , 2012, The Journal of clinical investigation.

[12]  G. Basso,et al.  Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia. , 2012, Blood.

[13]  K. Wheatley,et al.  Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial , 2011, British journal of haematology.

[14]  D. Neuberg,et al.  Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia , 2011, The Journal of experimental medicine.

[15]  L. Zon,et al.  Zebrafish as a model for normal and malignant hematopoiesis , 2011, Disease Models & Mechanisms.

[16]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[17]  G. Basso,et al.  ICER Evokes Dusp1-p38 Pathway Enhancing Chemotherapy Sensitivity in Myeloid Leukemia , 2011, Clinical Cancer Research.

[18]  C. Pui,et al.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Leach,et al.  Zebrafish models for cancer. , 2011, Annual review of pathology.

[20]  K. Jahnukainen,et al.  Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Yujin Hoshida,et al.  Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment , 2010, PloS one.

[22]  S. Shurtleff,et al.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  K. Sakamoto,et al.  CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis , 2009, Advances in hematology.

[24]  J. Downing,et al.  Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia , 2009, Proceedings of the National Academy of Sciences.

[25]  Giuseppe Basso,et al.  miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. , 2009, Cancer research.

[26]  R. Peterson,et al.  Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation , 2009, Nature chemical biology.

[27]  E. Solary,et al.  MOZ/TIF2‐induced acute myeloid leukaemia in transgenic fish , 2008, British journal of haematology.

[28]  G. Basso,et al.  ICER expression inhibits leukemia phenotype and controls tumor progression , 2008, Leukemia.

[29]  T. Mikkelsen,et al.  Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.

[30]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[31]  Jill P. Mesirov,et al.  GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..

[32]  D. Traver,et al.  Definitive hematopoiesis initiates through a committed erythromyeloid progenitor in the zebrafish embryo , 2007, Development.

[33]  J. Malaterre,et al.  CREB activity modulates neural cell proliferation, midbrain-hindbrain organization and patterning in zebrafish. , 2007, Developmental biology.

[34]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[35]  Huating Wang,et al.  NF-κB Regulation of YY1 Inhibits Skeletal Myogenesis through Transcriptional Silencing of Myofibrillar Genes , 2007, Molecular and Cellular Biology.

[36]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[37]  A. Look,et al.  NOTCH1-Induced T-Cell Leukemia in Transgenic Zebrafish. , 2006 .

[38]  H. Tsai,et al.  TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia , 2006, Proceedings of the National Academy of Sciences.

[39]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[40]  Allan R. Brasier,et al.  Identification of Direct Genomic Targets Downstream of the Nuclear Factor-κB Transcription Factor Mediating Tumor Necrosis Factor Signaling* , 2005, Journal of Biological Chemistry.

[41]  N. Rao,et al.  The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. , 2005, Cancer cell.

[42]  Richard G. Jenner,et al.  Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Zon,et al.  The ‘definitive’ (and ‘primitive’) guide to zebrafish hematopoiesis , 2004, Oncogene.

[44]  B. Paw,et al.  The pu.1 promoter drives myeloid gene expression in zebrafish. , 2004, Blood.

[45]  David M Langenau,et al.  Myc-Induced T Cell Leukemia in Transgenic Zebrafish , 2003, Science.

[46]  J. Griffin,et al.  The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.

[47]  S. Bhatia,et al.  Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. , 2002, Blood.

[48]  Pu Zhang,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.

[49]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[50]  F. Wilcoxon,et al.  Individual comparisons of grouped data by ranking methods. , 1946, Journal of economic entomology.

[51]  R. Arceci.  Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study , 2010 .

[52]  A. Aml.  cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression , 2007 .

[53]  G. Behre,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. , 2001, Nature genetics.